Timber Creek Capital Management LLC Biogen Inc. Transaction History

Timber Creek Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$275.25 - $318.06 $1,101 - $1,272	4 New	4 $1,000
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $1.39 Million - $1.75 Million	-7,150 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $1.84 Million - $2.37 Million	-8,225 Reduced 53.5%	7,150 $1.72 Million
Q3 2021 Oct 08, 2021	SELL	$282.99 - $369.05 $20,375 - $26,571	-72 Reduced 0.47%	15,375 $4.35 Million
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $783,734 - $1.25 Million	3,026 Added 24.36%	15,447 $5.35 Million
Q1 2021 Apr 19, 2021	BUY	$242.95 - $284.63 $137,266 - $160,815	565 Added 4.77%	12,421 $3.47 Million
Q4 2020 Jan 25, 2021	BUY	$236.26 - $355.63 $1.19 Million - $1.79 Million	5,038 Added 73.89%	11,856 $2.9 Million
Q3 2020 Oct 20, 2020	BUY	$264.77 - $305.71 $1.81 Million - $2.08 Million	6,818 New	6,818 $1.93 Million
Q2 2017 Aug 11, 2017	BUY	N/A	0	0 $0

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Timber Creek Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Timber Creek Capital Management LLC with notifications on news.